Twist Bioscience
New Products Posted to GenomeWeb: Illumina, Twist Bioscience, Stemcell, IDT, More
New products and services posted to GenomeWeb for the week of Aug. 5, 2024.
Twist Bioscience Reports 28 Percent Rise in Fiscal Q3 Revenues, Increases 2024 Guidance
The synthetic DNA maker reported record revenues of $81.5 million, beating the Wall Street estimate on the top line but missing on the bottom line.
GenomeWeb Top 40 Down 3 Percent in June Despite Gains in Broader Market
The Dow Jones Industrial Average rose 1 percent, the Nasdaq gained 6 percent, and the Nasdaq Biotech Index increased 3 percent.
GenomeWeb Top 40 up 1 Percent in May, Though Gains Trail Broader Market
The Dow Jones Industrial Average rose 3 percent, the Nasdaq rose 7 percent, and the Nasdaq Biotech Index rose 6 percent.
Oxford Nanopore Technologies, Twist Bioscience Partner for Pharmacogenomics Beta Program
The program aims to integrate Twist’s NGS target enrichment technology with Oxford Nanopore’s sequencing platform to develop long-read PGx workflows.